Clinical Trial Update: Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effectiveness of itopride hydrochloride in irritable bowel syndrome with constipation; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Itopride HCl (Itopride hydrochloride)

Snippet

Sponsor: Abbott | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED